Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,057
Closed -$95.1K 1405
2026
Q1
$95.1K Sell
13,057
-824
-6% -$7.46K ﹤0.01% 1202
2025
Q4
$134K Sell
13,881
-12,245
-47% -$127K ﹤0.01% 1154
2025
Q3
$318K Sell
26,126
-9,712
-27% -$102K 0.01% 985
2025
Q2
$290K Sell
35,838
-25,707
-42% -$180K 0.01% 991
2025
Q1
$444K Buy
61,545
+10,689
+21% +$77.7K 0.01% 829
2024
Q4
$350K Buy
50,856
+36,651
+258% +$252K 0.01% 893
2024
Q3
$196K Sell
14,205
-9,258
-39% -$86.5K 0.01% 1011
2024
Q2
$247K Buy
23,463
+9,258
+65% +$117K 0.01% 967
2024
Q1
$196K Sell
14,205
-5,915
-29% -$92.4K 0.01% 1010
2023
Q4
$391K Buy
20,120
+9,795
+95% +$181K 0.01% 813
2023
Q3
$219K Sell
10,325
-5,174
-33% -$134K 0.01% 911
2023
Q2
$515K Buy
15,499
+2,372
+18% +$87.3K 0.02% 638
2023
Q1
$516K Buy
13,127
+1,867
+17% +$77.6K 0.02% 639
2022
Q4
$475K Sell
11,260
-1,823
-14% -$70.1K 0.03% 591
2022
Q3
$437K Buy
13,083
+2,240
+21% +$93.3K 0.03% 532
2022
Q2
$470K Buy
+10,843
New +$498K 0.03% 489

Other funds holding NUS

Ethic Inc's NUS Position: Q2 2026 in Review

Ethic Inc sold out of Nu Skin (NUS) in Q2 2026, closing a stake of 13,057 shares — an estimated $95.1K sold.

Ethic Inc first reported a position in NUS in Q2 2022 and held it in 16 quarters. The position peaked at $516K in Q1 2023. 25 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • Ethic Inc reported no remaining Nu Skin position as of Q2 2026 after selling out during the quarter.
  • Ethic Inc sold 13,057 Nu Skin shares in Q2 2026, an estimated $95.1K.
  • Ethic Inc first reported a position in Nu Skin in Q2 2022 and held it in 16 quarters.
  • Ethic Inc's Nu Skin position peaked at $516K in Q1 2023.
  • 25 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.